Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients
Titel:
Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients
Auteur:
Sánchez-Muñoz, A. Plata-Fernández, Y. Fernández, M. Jaén-Morago, A. Fernández-Navarro, M. Torre-Cabrera, C. de la Ramirez-Tortosa, C. Pascual, J. Alba, E. Sánchez-Rovira, P.